Podcast Episodes
Back to Search
Pharmaceutical Executive Daily: Lilly and Novo Nordisk Bring GLP-1's to TrumpRX
In today’s Pharmaceutical Executive Daily, we cover Eli Lilly and Novo Nordisk’s plans to bring their leading weight-loss medications to the TrumpRx …
6 months, 1 week ago
Pharmaceutical Executive Daily: Novo Nordisk's Amended Acquisition Proposal
In today’s Pharmaceutical Executive Daily, we cover Novo Nordisk’s amended proposal to acquire Metsera, the State of Texas’ attempt to block Kenvue’s…
6 months, 2 weeks ago
Pharmaceutical Executive Daily: Kimberly-Clark’s $48.7 Billion Acquisition of Kenvue
In today’s Pharmaceutical Executive Daily, we cover Kimberly-Clark’s $48.7 billion acquisition of Kenvue, Cencora’s $1 billion investment to strength…
6 months, 2 weeks ago
Pharmaceutical Executive Daily: Pfizer Files Lawsuits Against Metsera and Novo Nordisk
In today’s Pharmaceutical Executive Daily, we cover Pfizer’s lawsuits against Metsera and Novo Nordisk over alleged intellectual property infringemen…
6 months, 2 weeks ago
Pharmaceutical Executive Daily: George Tidmarsh Resigns from FDA
In today’s Pharmaceutical Executive Daily, we cover Eli Lilly’s plan to submit its oral GLP-1 candidate for FDA priority review, the departure of sen…
6 months, 2 weeks ago
Pharmaceutical Executive Daily: Novo Nordisk's Unsolicited Acquisition Proposal
In today’s Pharmaceutical Executive Daily, we cover Novo Nordisk’s unsolicited proposal to acquire Metsera, renewed legal action against Tylenol’s ma…
6 months, 2 weeks ago
Pharmaceutical Executive Daily: Thermo Fisher's $8.8 Billion Acquisition of Clario Holdings
In today’s Pharmaceutical Executive Daily, we cover Thermo Fisher’s $8 billion agreement to acquire Clario Holdings, Eli Lilly’s partnership with Wal…
6 months, 2 weeks ago
Pharmaceutical Executive Daily: Lilly and NVIDIA Create AI Supercomputer
In today’s Pharmaceutical Executive Daily, we cover Eli Lilly’s partnership with NVIDIA to develop an AI supercomputer for drug discovery, a surge in…
6 months, 3 weeks ago
Pharmaceutical Executive Daily: Organon CEO Kevin Ali Resigns
In today’s Pharmaceutical Executive Daily, we cover the resignation of Organon CEO Kevin Ali following an internal investigation tied to Nexplanon sa…
6 months, 3 weeks ago
Pharmaceutical Executive Daily: New Research Suggests Ozempic May Reduce Biological Age
In today’s Pharmaceutical Executive Daily, we cover the FDA approval of Bayer’s Lynkuet for menopausal hot flashes, new research suggesting Ozempic m…
6 months, 3 weeks ago